CHU de Bordeaux Hop St ANDRE

Bordeaux, Gironde 33075

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cancer, Atopic Dermatitis, Biliary Tract Cancer, Metastatic Cancer, Psoriasis

Studies at this site

• A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early